Abstract
Introduction
Periprosthetic joint infection (PJI) remains the most devasting complication after total joint arthroplasty (TJA). There has been a significant focus on this topic in recently-published medical literature. However, relatively little has been published about PJI in patients with rheumatoid arthritis (RA), which are often physiologically frail and immunocompromised. A better understanding of PJI in this patient population is therefore crucial. The main aims of this paper are to (1) report complication and mortality rates in a cohort of PJI-RA patients; and (2) clinically characterize them.
Methods
Medical and surgical records of all RA PJI patients treated surgically from 2003 to 2020 were retrospectively reviewed. Medical history, physical examination, reactive protein (CRP) level, procalcitonin, white blood cell (WBC) count, joint aspiration results, and cultures were used to determine PJI.
Results
54PJIs, 49 of them chronic, were treated in 53RA patients. Mean patient age was 65 yrs. (range = 32–88); 33females and 20 males (one bilateral hip). The overall mortality rate was 18.9%(n = 10), with five deaths directly attributed to PJI. Staphylococci accounted for 34 infections (63%), while 11(20.4%) had multiorganism infections and six culture-negative PJI. At the end of treatment 79.6%(n = 43) still had an implanted TJR, 7.4% (n = 4) had spacers, 5.6%(n = 3) had undergone resection arthroplasty, 3.7%(n = 2) arthrodesis, and one each amputation and exarticulation.
Conclusions
Mortality and specially complication rates were (are) high in this RA patients group presenting PJI. Delays to diagnosis and treatment may explain some of these poor outcomes.
Level of evidence
A cohort level III retrospective study.
Similar content being viewed by others
References
Berbari EF et al (2006) Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 42(2):216–223
Jr Harris ED (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322(18):1277–89
Alarcon GS et al (1995) Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients. Ann Rheum Dis 54(9):708–712
Amaya-Amaya J, Mantilla RD et al (2013) Autoimmunity: from bench to bedside. El Rosario University Press, Gogota, Colombia
Hsieh PH, Huang KC, Shih HN (2013) Prosthetic joint infection in patients with rheumatoid arthritis: an outcome analysis compared with controls. PLoS One 8(8):e71666
Peltomaa R et al (2002) Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis 61(10):889–894
Wolfe F et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37(4):481–494
Thomas E et al (2003) National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 30(5):958–965
Bongartz T et al (2008) Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 59(12):1713–1720
Berbari EF et al (1998) Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27(5):1247–1254
Lenguerrand E et al (2018) Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study. Lancet Infect Dis 18(9):1004–1014
Lenguerrand E et al (2019) Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales. Lancet Infect Dis 19(6):589–600
Shahi A et al (2017) In-hospital mortality in patients with periprosthetic joint infection. J Arthroplasty 32(3):948-952 e1
Parvizi J, Fassihi SC, Enayatollahi MA (2016) Diagnosis of periprosthetic joint infection following hip and knee arthroplasty. Orthop Clin North Am 47(3):505–515
Cordtz R et al (2020) Risk of medical complications following total hip or knee arthroplasty in patients with rheumatoid arthritis: a register-based cohort study from Denmark. Semin Arthritis Rheum 50(1):30–35
Cordtz RL et al (2018) Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers. Ann Rheum Dis 77(2):281–288
Thakrar RR et al (2019) Indications for a single-stage exchange arthroplasty for chronic prosthetic joint infection: a systematic review. Bone Joint J 101-B(1_Supple_A):19–24
Singh JA et al (2015) Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet 386(9990):258–265
Goodman SM et al (2016) Management of perioperative tumour necrosis factor alpha inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis. Rheumatology (Oxford) 55(3):573–582
Eka A, Chen AF (2015) Patient-related medical risk factors for periprosthetic joint infection of the hip and knee. Ann Transl Med 3(16):233
Premkumar A et al (2018) Periprosthetic joint infection in patients with inflammatory joint disease: prevention and diagnosis. Curr Rheumatol Rep 20(11):68
Schwarz EM et al (2019) 2018 international consensus meeting on musculoskeletal infection: research priorities from the general assembly questions. J Orthop Res 37(5):997–1006
Bozic KJ et al (2012) Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am 94(9):794–800
Parvizi J et al (2001) Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am 83(10):1524–1528
Parvizi J et al (2001) Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am 83(8):1157–1161
Yao JJ et al (2018) Long-term mortality after revision THA. Clin Orthop Relat Res 476(2):420–426
Singh N et al (2019) Risk of recurrent staphylococcus aureus prosthetic joint infection in rheumatoid arthritis patients-a nationwide cohort study. Open Forum Infect Dis 6(11):ofz451
Buchholz HW et al (1981) Management of deep infection of total hip replacement. J Bone Joint Surg Br 63-B(3):342–53
Sihvonen S et al (2006) Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids A population-based cohort study. J Rheumatol 33(9):1740–1746
Borgas Y et al (2020) Anti-rheumatic treatment and prosthetic joint infection: an observational study in 494 elective hip and knee arthroplasties. BMC Musculoskelet Disord 21(1):410
Fink B et al (2020) C-reactive protein is not a screening tool for late periprosthetic joint infection. J Orthop Traumatol 21(1):2
Tahta M et al (2019) Does inflammatory joint diseases affect the accuracy of infection biomarkers in patients with periprosthetic joint infections? A prospective comparative reliability study. J Orthop Sci 24(2):286–289
Funding
There was no outside funding for this project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has any conflict of interest relevant to the topic of this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
de Araujo, L.C.T., Westerholt, A., Sandiford, A.N. et al. Periprosthetic joint infections in patients with rheumatoid arthritis are associated with higher complication and mortality rates. Arch Orthop Trauma Surg (2024). https://doi.org/10.1007/s00402-024-05248-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00402-024-05248-y